Xeris Biopharma Holdings, Inc. (XERS)
5.54
-0.04
(-0.72%)
USD |
NASDAQ |
Mar 20, 09:40
Xeris Biopharma Holdings Shareholders Equity (Quarterly) : 13.69M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Zoetis, Inc. | 3.331B |
| Harrow, Inc. | 52.45M |
| Zymeworks, Inc. | 268.50M |
| Vir Biotechnology, Inc. | 765.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 392.94M |
| Total Liabilities (Quarterly) | 379.25M |
| Debt to Equity Ratio | 18.85 |
| Current Ratio | 2.193 |
| Net Debt Paydown Yield | 0.20% |